Rhea Nersesian
Genentech · 7 works · 200 citations · h-index 4
Top works
- Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade
- Entrectinib in ROS1-positive advanced non-small cell lung cancer: the phase 2/3 BFAST trial
- Diagnosis of the lyme disease spirochete Borrelia burgdorferi
- Survey of CF mutations in the clinical laboratory
- Efficacy/safety of entrectinib in patients (pts) with ROS1-positive (ROS1+) advanced/metastatic NSCLC from the Blood First Assay Screening Trial (BFAST).
- A targeted amplicon next-generation sequencing assay for tryptase genotyping to support personalized therapy in mast cell-related disorders